EHA 2016 | The work of ERIC, the European Research Initiative on CLL
Kostas Stamatopoulos
• 9 Jun 2016
Kostas Stamatopoulos, MD, PhD from CERTH Institute of Applied Biosciences, Thessaloniki, Greece gives an overview of the European Research Initiative on CLL (ERIC), which held a General Assembly at the European Hematology Association (EHA) 2016 Annual Congress in Copenhagen, Denmark. The aim of ERIC is to promote research that will improve patient management, strengthen collaboration and disseminate good practice. One of the projects is to complete a census of chronic lymphocytic leukemia (CLL) patients throughout Europe. Dr Stamatopoulos also discusses the deletion of chromosome 17p or aberrant TP53 and the work ERIC has done to improve the treatment of affected patients.
